Cargando…

Multi-center evaluation of machine learning-based radiomic model in predicting disease free survival and adjuvant chemotherapy benefit in stage II colorectal cancer patients

BACKGROUND: Our study aimed to explore the potential of radiomics features derived from CT images in predicting the prognosis and response to adjuvant chemotherapy (ACT) in patients with Stage II colorectal cancer (CRC). METHODS: A total of 478 patients with confirmed stage II CRC, with 313 from Sha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Hui, Hu, Muni, Ma, Yanru, Yao, Xun, Lin, Xiaozhu, Li, Menglei, Li, Yue, Wu, Zhiyuan, Shi, Debing, Tong, Tong, Chen, Haoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401876/ https://www.ncbi.nlm.nih.gov/pubmed/37537659 http://dx.doi.org/10.1186/s40644-023-00588-1

Ejemplares similares

Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
por: Xie, Dong, et al.
Publicado: (2020)

Assessment of Primary Colorectal Cancer CT Radiomics to Predict Metachronous Liver Metastasis
por: Li, Yue, et al.
Publicado: (2022)

A clinical-radiomics nomogram for the preoperative prediction of lymph node metastasis in colorectal cancer
por: Li, Menglei, et al.
Publicado: (2020)

Prognostic and predictive value of radiomics signatures in stage I‐III colon cancer
por: Dai, Weixing, et al.
Publicado: (2020)

A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer
por: Cao, Bangrong, et al.
Publicado: (2017)

Promotion of the Warburg effect is associated with poor benefit from adjuvant chemotherapy in colorectal cancer
por: Kitazawa, Masashi, et al.
Publicado: (2020)

A potential biomarker based on clinical-radiomics nomogram for predicting survival and adjuvant chemotherapy benefit in resected node-negative, early-stage lung adenocarcinoma
por: Ma, Xiaoling, et al.
Publicado: (2022)

Adjuvant chemotherapy for colorectal cancer
por: Maughan, T S
Publicado: (2001)

Faecal microbiota transplantation, a promising way to treat colorectal cancer
por: Ma, Yanru, et al.
Publicado: (2019)

Whether Patients With Stage Ⅱ/Ⅲ Colorectal Cancer Benefit From Adjuvant Chemotherapy: A Modeling Analysis of Literature Aggregate Data
por: Zha, Sijie, et al.
Publicado: (2022)

DKK1 as a robust predictor for adjuvant platinum chemotherapy benefit in resectable pStage II-III gastric cancer
por: Fan, Zhiyuan, et al.
Publicado: (2022)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Development and validation of a polygenic hazard score to predict prognosis and adjuvant chemotherapy benefit in early-stage non-small cell lung cancer
por: Li, Dan-Hua, et al.
Publicado: (2022)

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
por: Guo, Jianping, et al.
Publicado: (2023)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors
por: Sobash, Philip T., et al.
Publicado: (2022)

Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer
por: Xie, Yuquan, et al.
Publicado: (2018)

Adjuvant chemotherapy or no adjuvant chemotherapy? A prediction model for the risk stratification of recurrence or metastasis of nasopharyngeal carcinoma combining MRI radiomics with clinical factors
por: Wu, Qiaoyuan, et al.
Publicado: (2023)

High level of unmet needs and anxiety are associated with delayed initiation of adjuvant chemotherapy for colorectal cancer patients
por: Zhu, Li, et al.
Publicado: (2020)

Circulating Methylated SEPT9 DNA Analyses to Predict Recurrence Risk and Adjuvant Chemotherapy Benefit in Stage II to III Colorectal Cancer
por: Yuan, Zhen, et al.
Publicado: (2022)

Immunological nomograms predicting prognosis and guiding adjuvant chemotherapy in stage II colorectal cancer
por: Feng, Yang, et al.
Publicado: (2019)

The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma
por: Zhao, Zhuang, et al.
Publicado: (2020)

Timing of Adjuvant Chemotherapy in Colorectal Cancer Patients
por: Baek, Moo-Jun
Publicado: (2013)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
por: Glimelius, Bengt, et al.
Publicado: (2020)

The value of radiomics-based CT combined with machine learning in the diagnosis of occult vertebral fractures
por: Li, Wu-Gen, et al.
Publicado: (2023)

Size and number of lymph nodes were risk factors of recurrence in stage II colorectal cancer
por: Tong, Shanyou, et al.
Publicado: (2023)

Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022)

CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma
por: Song, Bolin, et al.
Publicado: (2023)

Impact of Adjuvant Chemotherapy in Patients With Curatively Resected Stage IV Colorectal Cancer
por: Kobayashi, Hirotoshi, et al.
Publicado: (2015)

Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer
por: Ihara, Keisuke, et al.
Publicado: (2019)

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
por: Lee, Kil-yong, et al.
Publicado: (2019)

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
por: Chen, Po-Huang, et al.
Publicado: (2022)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018)

The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy
por: Filipe, W. F., et al.
Publicado: (2023)

DWI-based radiomic signature: potential role for individualized adjuvant chemotherapy in intrahepatic cholangiocarcinoma after partial hepatectomy
por: Yang, Yang, et al.
Publicado: (2022)

Radiomics based on machine learning algorithms could predict prognosis and postoperative chemotherapy benefits of patients with gastric cancer: a retrospective cohort study
por: Xiang, Yilan, et al.
Publicado: (2023)

Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate‐adjusted analysis at the pre‐adjuvant chemotherapy timing
por: Fu, Ningzhen, et al.
Publicado: (2022)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kn4mo2vl59nqtnriq3pbip0hke